Skip to main content

09-05-2024 | Splenectomy | Image of the Month

Sinus Formation and Subsequent Bleeding After Splenectomy

Authors: Zewen Xu, Di Chen, Na Liu

Published in: Digestive Diseases and Sciences

Login to get access


A 47-year-old male patient was admitted to the gastroenterology ward with a 3-day history of melena. The physical examination revealed no symptoms of peritonitis, such as abdominal pain or fever. Abdominal CT demonstrated a high-density shadow in the greater curvature of the stomach (Fig. 1A). Subsequent endoscopic evaluation identified a sinus in the greater curvature of the upper gastric body, from which blood flowed and bubbles were visible after repeated irrigation (Fig. 1B). The patient later stated that he had a splenectomy plus portal vein disconnection more than one year ago.
Sinus Formation and Subsequent Bleeding After Splenectomy
Zewen Xu
Di Chen
Na Liu
Publication date
Springer US
Published in
Digestive Diseases and Sciences
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare